Back to News
Market Impact: 0.33

Should You Buy MP Materials Stock While It's Under $65?

MPAAPLNFLXNVDANDAQ
Commodities & Raw MaterialsTrade Policy & Supply ChainInfrastructure & DefenseCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookInvestor Sentiment & PositioningTechnology & Innovation
Should You Buy MP Materials Stock While It's Under $65?

MP Materials, owner and operator of the U.S. Mountain Pass rare-earth mine, has become a policy and supply-chain focal point after a $400 million Department of Defense investment and commercial interest from Apple, and it plans to begin shipping U.S.-made NdFeB permanent magnets from its Fort Worth facility by year-end with fuller ramp through 2026—representing a strategic move to displace China in the magnet supply chain. Recent results showed record NdPr oxide output, roughly $22 million in magnet-precursor revenue and a smaller-than-expected loss with management forecasting profitability next quarter; the company also aims to commission a heavy rare-earth separation plant (Dy, Tb) in mid-2026. Material execution risks remain, however—scaling magnet factories will pressure near-term margins and is essential for meaningful revenue growth—so meeting production milestones and continued government support will determine whether current sub-$65 share levels are an attractive entry for investors.

Analysis

MP Materials occupies a strategic position as the owner and operator of the Mountain Pass rare-earth mine and has secured a $400 million Department of Defense investment to expand U.S. magnet manufacturing capacity. The stock traded as high as about $100 in October and has since pulled back to below $60, reflecting investor recalibration of near-term execution risk versus long-term strategic value. Operationally MP is advancing concrete milestones: management expects its Fort Worth facility to begin shipping U.S.-made NdFeB permanent magnets by year-end with a fuller ramp through 2026, and it plans to commission a heavy rare-earth separation plant for dysprosium and terbium in mid-2026. Recent results showed record NdPr-oxide output, roughly $22 million in magnet-precursor revenue, and a smaller-than-expected quarterly loss with guidance pointing to profitability next quarter, indicating early commercialization traction but limited current magnet capacity. The main investment case rests on execution and policy support: scaling magnet factories is capital- and time-intensive and will pressure near-term margins, yet successful ramp plus continued White House and commercial backing (Apple noted) could materially re-route U.S. supply chains away from China. Given the mildly positive sentiment and moderate market-impact score, outcomes will be binary and hinge on meeting the late-2025 to mid-2026 milestones.